Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
The latest announcement is out from Design Therapeutics ( (DSGN) ).
Design Therapeutics, Inc. has updated its corporate presentation to be used in meetings with investors, analysts, and others, which has been attached to a Current Report on Form 8-K. This update, although furnished for informational purposes, is not deemed filed under the Securities Exchange Act or the Securities Act, thus limiting its formal legal implications.
More about Design Therapeutics
YTD Price Performance: -26.74%
Average Trading Volume: 170,642
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $255.9M
For detailed information about DSGN stock, go to TipRanks’ Stock Analysis page.
